down arrow

Kerala Ayurveda

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE817B01025
  • NSEID:
  • BSEID: 530163
INR
339.85
-0.15 (-0.04%)
BSENSE

Apr 11, 12:50 PM

BSE+NSE Vol: 3.15 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

335.05343.25

52 Week

249.95486.90
Valuation
Technical
Day's Volume

CASH

3.15 k (4.81%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.04%

Held by 0 DIIs

Promoter

58.58%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Operating profit has grown by an annual rate -3.45% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 0 times
  • The company has been able to generate a Return on Capital Employed (avg) of 5.75% signifying low profitability per unit of total capital (equity and debt)
2

Flat results in Dec 24

3

With ROCE of 8, it has a Very Expensive valuation with a 5 Enterprise value to Capital Employed

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 409 Cr (Micro Cap)

stock-summary
P/E

409.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.56

stock-summary
Return on Equity

7.32%

stock-summary
Price to Book

11.35

Revenue and Profits (1 Year):
Net Sales:
31 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-3 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
20.49%
0%
20.49%
1 Year
30.34%
0%
30.34%
2 Years
272.03%
0%
272.03%
3 Years
322.44%
0%
322.44%
4 Years
540.62%
0%
540.62%
5 Years
705.33%
0%
705.33%

Kerala Ayurveda for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
10.90%
EBIT Growth (5y)
-3.45%
EBIT to Interest (avg)
0.79
Debt to EBITDA (avg)
19.77
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.02
Tax Ratio
36.29%
Dividend Payout Ratio
0
Pledged Shares
13.36%
Institutional Holding
0.04%
ROCE (avg)
5.91%
ROE (avg)
10.70%
Valuation key factors
Factor
Value
P/E Ratio
409
Industry P/E
33
Price to Book Value
11.35
EV to EBIT
97.14
EV to EBITDA
56.75
EV to Capital Employed
5.04
EV to Sales
4.00
PEG Ratio
2.68
Dividend Yield
NA
ROCE (Latest)
7.99%
ROE (Latest)
7.32%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

13.3599

Mutual Funds

Held by 1 Schemes (0.02%)

FIIs

Held by 0 FIIs

Promoter with highest holding

Katra Holdings Ltd (53.97%)

Highest Public shareholder

Porinju Veliyath (5.18%)

Individual Investors Holdings

32.19%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 2.37% vs 10.70% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -184.75% vs 965.62% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "31.13",
          "val2": "30.41",
          "chgp": "2.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.19",
          "val2": "5.53",
          "chgp": "-121.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.43",
          "val2": "0.72",
          "chgp": "-40.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.89",
          "val2": "3.41",
          "chgp": "-184.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3.82%",
          "val2": "18.18%",
          "chgp": "-22.00%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 18.38% vs 11.09% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 861.22% vs -450.00% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "57.89",
          "val2": "48.90",
          "chgp": "18.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6.34",
          "val2": "2.34",
          "chgp": "170.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.18",
          "val2": "2.16",
          "chgp": "-45.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.53",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.73",
          "val2": "-0.49",
          "chgp": "861.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.95%",
          "val2": "4.79%",
          "chgp": "6.16%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 18.35% vs 11.64% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 156.38% vs -55.21% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "89.02",
          "val2": "75.22",
          "chgp": "18.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.15",
          "val2": "3.35",
          "chgp": "53.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.61",
          "val2": "2.77",
          "chgp": "-41.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.53",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.84",
          "val2": "-1.49",
          "chgp": "156.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.79%",
          "val2": "4.45%",
          "chgp": "1.34%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 15.14% vs 17.01% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -425.53% vs -80.08% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "102.75",
          "val2": "89.24",
          "chgp": "15.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6.56",
          "val2": "2.25",
          "chgp": "191.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.46",
          "val2": "4.82",
          "chgp": "-7.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "2.83",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.53",
          "val2": "0.47",
          "chgp": "-425.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.38%",
          "val2": "2.52%",
          "chgp": "3.86%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
31.13
30.41
2.37%
Operating Profit (PBDIT) excl Other Income
-1.19
5.53
-121.52%
Interest
0.43
0.72
-40.28%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.89
3.41
-184.75%
Operating Profit Margin (Excl OI)
-3.82%
18.18%
-22.00%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 2.37% vs 10.70% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -184.75% vs 965.62% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
57.89
48.90
18.38%
Operating Profit (PBDIT) excl Other Income
6.34
2.34
170.94%
Interest
1.18
2.16
-45.37%
Exceptional Items
0.00
0.53
-100.00%
Consolidate Net Profit
3.73
-0.49
861.22%
Operating Profit Margin (Excl OI)
10.95%
4.79%
6.16%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 18.38% vs 11.09% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 861.22% vs -450.00% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
89.02
75.22
18.35%
Operating Profit (PBDIT) excl Other Income
5.15
3.35
53.73%
Interest
1.61
2.77
-41.88%
Exceptional Items
0.00
0.53
-100.00%
Consolidate Net Profit
0.84
-1.49
156.38%
Operating Profit Margin (Excl OI)
5.79%
4.45%
1.34%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 18.35% vs 11.64% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 156.38% vs -55.21% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
102.75
89.24
15.14%
Operating Profit (PBDIT) excl Other Income
6.56
2.25
191.56%
Interest
4.46
4.82
-7.47%
Exceptional Items
0.00
2.83
-100.00%
Consolidate Net Profit
-1.53
0.47
-425.53%
Operating Profit Margin (Excl OI)
6.38%
2.52%
3.86%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 15.14% vs 17.01% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -425.53% vs -80.08% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Kerala Ayurveda Ltd stock-summary
stock-summary
Kerala Ayurveda Ltd
Micro Cap
Pharmaceuticals & Drugs
Kerala Ayurveda Ltd was established on 6th July 1992. The Company is engaged in manufacture of Ayurveda products, Ayurveda Research, Academies, Clinics, Hospitals, Ayurvedic Wellness Resorts and Services , cultivation of herbs and maintaining herbarium of medicinal plants. The Company emerged as a frontline manufacturer of speciality patent ayurvedic medicines - tussnil, liposem and mathrukalpam. The company came out with a public issue in Feb.
Company Coordinates stock-summary
Company Details
VII/415 Nedumbassery, Athani P O Aluva Ernakulam Kerala : 683585
stock-summary
Tel: 91-484-2476301/2/3/4
stock-summary
http://www.keralaayurveda.biz
stock-summary
info@keralaayurveda.biz
Registrar Details
Integrated Enterprises (India) Ltd , II Floor , Kences Towers, No 1 Ramakrishna Street, North Usman Road, T Nagar, Chennai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."